Cargando…
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
A large number of adenoviral agents are being developed for the treatment of cancer. However, the treatment-related death of a patient with ornithine transcarbamylase deficiency following adenovirus administration by hepatic artery has led to serious concerns regarding the safety of intravascular ad...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091735/ https://www.ncbi.nlm.nih.gov/pubmed/12522437 http://dx.doi.org/10.1038/sj.cgt.7700539 |